معرفی
Ting-Ting Wu serves as Professor-in-residence and Department Vice Chair in the Department of Molecular and Medical Pharmacology within the David Geffen School of Medicine at the University of California Los Angeles. Her academic leadership position reflects her significant contributions to the field of molecular virology and pharmacology.
Dr. Wu's research focuses on the molecular mechanisms of gammaherpesvirus infection, with particular emphasis on Kaposi's sarcoma-associated herpesvirus (KSHV) and murine gammaherpesvirus 68. Her work investigates viral gene expression regulation, particularly mRNA export during infection, viral replication mechanisms, and the development of novel vaccination strategies against oncogenic herpesviruses. Her research bridges virology, molecular pharmacology, and cancer biology, with implications for understanding viral tumorigenesis and developing targeted therapies.
Analysis of Dr. Wu's publication record reveals a consistent focus on herpesvirus molecular biology, with particular attention to viral gene expression mechanisms and vaccine development. Her work spans fundamental virology and translational applications, demonstrating how basic research on viral replication can inform therapeutic development. The progression of her research from molecular mechanisms to vaccine prospects highlights an integrated approach to combating herpesvirus-associated diseases.
Dr. Wu currently leads multiple significant research projects funded by the National Institutes of Health, including the principal investigator role on 'Regulation of mRNA export during gammaherpesvirus infection' (R01DE028774) and co-principal investigator role on 'In situ atomic structures of the Kaposi's sarcoma-associated herpesvirus portal-terminase complex and glycoproteins' (R01DE025567), which extends through 2025. Her previous work includes 'Genetic Analysis of Interactions Between Oral Innate Immunity and a Herpesvirus' (R21DE018337).
Dr. Wu maintains an active research program within the Molecular and Medical Pharmacology Department at UCLA, contributing to the department's strengths in molecular virology and pharmacological approaches to infectious diseases. Her work connects with broader research themes in viral pathogenesis, cancer biology, and therapeutic development within the medical school.
